BLOG

Blood microsampling is a less invasive and simplified alternative to traditional venipuncture, and provides significant advantages in preclinical and clinical studies alike. This month's blog includes an overview, and additional information.

Vaccine development is a complex, time-consuming process at the best of times. Now, facing a world-wide pandemic of a novel virus, understanding the science, the regulatory process, and the desire for an immunization solution has never been more crucial.

Get to know Francis Douville, Senior Vice President of Technical Operations at Altasciences' preclinical facility in Seattle, Washington.

Choosing the right CRO as a partner for your drug development programs is a vitally important step to achieving critical decision making early on for important milestones, and ultimately getting your molecule from discovery to market efficiently.

Artificial intelligence, or AI, has been on the radar screen as a possible tool to improve drug development, and clinical trial design and conduct for some time. This month's blog covers some of the advancements.

Get to know David Grégoire, Vice President of Compliance and Regulatory Affairs at Altasciences.